Hamburger Menu
Catalog
IASLC 2021 World Conference on Lung Cancer (WCLC) ...
IASLC 2021 World Conference on Lung Cancer (WCLC) Highlights
Webinar | English | 1 Hr
Create Account
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Summary
Join Drs. Harpole, Higgins, and Stinchcombe as they discuss the latest developments presented during the scientific and educational program at 2021 World Conference on Lung Cancer Worldwide Virtual Event. The webinar will consist of three 15 minute presentations followed by a 15 minute time for question and answers. This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, pharmacists, patient advocates, and researchers who specialize in diagnostic radiology, hematology, pulmonary medicine, palliative care, medical oncology, thoracic surgery, and radiation oncology.
Faculty
Dr. Kristin Higgins
Nothing to Disclose
Dr. David Harpole
Scientific Advisory Board: AstraZeneca, Medtronic, Novartis
Steering Committee: AEGEAN
Dr. Thomas Stinchcombe
Advisory Board (ended): Takeda, AstraZeneca, Genentech/Roche, Foundation Medicine, Pfizer, EMD Serono, Novartis, Daiichi Sankyo, Lilly, Medtronic, Puma Biotechnology, Janssen Oncology, Regeneron
Research funding from ineligible companies: Genentech/Roche, Blueprint Medicines, AstraZeneca, Takeda, Advaxis, Regeneron (institution)
Learning Objective
At the conclusion of this activity, participants will be able to:
Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
Explain advances in the multidisciplinary management of patients in relation to current standards of care.
Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.
×
IASLC 2021 World Conference on Lung Cancer (WCLC) Highlights Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English